Radiation dosimetry from breast milk excretion of radioiodine and pertechnetate

Journal Article · Wed Oct 01 00:00:00 EDT 1986 · J. Nucl. Med.; (United States)

OSTI ID:6933892

Hedrick, W R; Di Simone, R N; Keen, R L

Measurements were made of the activity in samples of breast milk obtained from a patient with postpartum thyroiditis following administration of (/sup 123/I)sodium iodide and subsequently (99mTc)pertechnetate 24 hr later. Both /sup 123/I and 99mTc were found to be excreted exponentially with an effective half-life of 5.8 hr and 2.8 hr, respectively. Less than 10% of the activity was incorporated into breast-milk protein. After administration of (/sup 123/I)sodium iodide breast feeding should be discontinued for 24-36 hr to reduce the absorbed dose to the child's thyroid.

• Research Organization: Aultman Hospital, Canton, OH
• OSTI ID: 6933892
• Journal Information: J. Nucl. Med.; (United States), Vol. 10
• Country of Publication: United States
• Language: English

Related Subjects

63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
IODINE 123
EXCRETION
MILK
RADIOACTIVITY
TECHNETIUM 99
BIOLOGICAL HALF-LIFE
INFANTS
PATIENTS
PREGNANCY
RADIATION DOSES
RADIONUCLIDE KINETICS
RADIOTHERAPY
THYROIDITIS
AGE GROUPS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BODY FLUIDS
CHILDREN
CLEARANCE
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
ENDOCRINE DISEASES
FOOD
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MATERIALS
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
RADIOISOTOPES
RADIOLOGY
TECHNETIUM ISOTOPES
THERAPY
YEARS LIVING RADIOISOTOPES
560161* - Radionuclide Effects
Kinetics
& Toxicology- Man